RFID technology improves accuracy and visibility of the medication
supply chain, from the production line to the patient
WASHINGTON–(BUSINESS WIRE)–Kit
Check, the leader in automated medication management solutions for
hospitals, and Avery
Dennison, a global leader in intelligent label solutions and the
world’s largest UHF RFID partner, are partnering to work directly with
drug manufacturers worldwide to apply RFID tags to medication packaging.
Tagging pharmaceutical products in this way helps improve patient safety
by enabling more accurate tracking and authentication of medication
through the entire supply chain, with the goal of reducing error rates
to nearly zero. It also eliminates the need for cost and labor-intensive
in-house medication tagging at hundreds of hospitals.
This partnership provides a complete solution for manufacturers and
contract manufacturing organizations (CMOs) that want to implement RFID
tagging in facilities that package drugs at high speeds, in line with
the U.S.
Food and Drug Administration’s (FDA) Current Good Manufacturing
Practices (CGMP), as well as for hospitals looking for end-to-end
inventory tracking. The solution provides downstream visibility for
manufacturers, giving them the ability to track a particular drug from
manufacturer to the point of use, and upstream visibility for hospital
pharmacies, enabling them to know the right drug is in the right place
at the right time for the right patient, as well as where that drug
originated.
“Working with Avery Dennison to tag drugs at the production source
enables us to track medications along every point in the supply chain,”
said Kevin MacDonald, CEO and co-founder of Kit Check. “We give our
customers visibility throughout the care continuum, and the accuracy of
Avery Dennison’s tags means better efficiency and safety for pharmacists
and patients. Kit Check provides the infrastructure to access the
medication information, and Avery Dennison’s global network ensures that
the tags work wherever you are – whether that’s on the production line
or in the hospital pharmacy. Kit Check and Avery Dennison have proven
capability in high-speed cGMP environments, and this partnership will
help accelerate the industry’s adoption of RFID to enable better drug
supply chain security and visibility.”
Kit Check is a leader in RFID-based medication inventory tracking and
automated tray processing in use at more than 500 hospitals in the U.S.
and Canada. It is a key partner of Avery Dennison in the healthcare
segment, and recently surpassed 60 million tagged medications scanned by
customer hospitals. Avery Dennison is a global leader in Radio Frequency
Identification (RFID)-enabled solutions, with more than 1,000 patents,
as well as applications and global manufacturing capabilities that have
produced more than 20 billion RFID tags and labels.
“Avery Dennison is proud to work with Kit Check to ensure performance,
reliability and data integrity for medication tracking at every step
along the supply chain,” says DJ Lee, director, global RFID channel,
Avery Dennison. “In collaboration with Kit Check, we’ve designed a
complete system that ensures RFID will work reliably and accurately in
hospitals and on high-speed packaging lines, ultimately helping to keep
patients safe in hospitals across the U.S.”
To learn more about Kit Check’s solutions, please visit them online at www.kitcheck.com.
To learn more about Avery Dennison, please visit them online at www.averydennison.com.
About Kit CheckTM
Kit Check is the leading provider of automated medication management
solutions for hospital pharmacies. Our solutions blend powerful machine
learning and advanced tracking technology to streamline medication
inventory, workflow, and auditing processes and help hospital pharmacies
cut costs, reduce risk, and get more done. To date, our more than 500
U.S. and Canadian hospital partners have tracked over 50 million
medications using the Kit Check and BluesightTM for
Controlled Substances software. More information about Kit Check and our
software solutions can be found at kitcheck.com.
About Avery Dennison
Avery Dennison (NYSE: AVY) is a global materials science and
manufacturing company specializing in the design and manufacture of a
wide variety of labeling and functional materials. The company’s
products, which are used in nearly every major industry, include
pressure-sensitive materials for labels and graphic applications; tapes
and other bonding solutions for industrial, medical and retail
applications; tags, labels and embellishments for apparel; and radio
frequency identification (RFID) solutions serving retail apparel and
other markets. Headquartered in Glendale, California, the company
employs approximately 30,000 employees in more than 50 countries.
Reported sales in 2018 were $7.2 billion. Learn more at www.averydennison.com.
Contacts
Media
Matter for Kit Check
Jessica
Wolter
kitcheck@matternow.com